Breaking News

Metrics Adds Formulation Scientist

February 14, 2013

DeHart to oversee formulation and manufacturingof clinical trial materials

Dr. Michael DeHart has joined Metrics, Inc. as a new formulation scientist. Dr. DeHart will manage all aspects of personnel and operations related to formulating and manufacturing pharmaceutical materials for Phase I-III clinical trials. He is also responsible for scale up and validation of clinical trial materials, and manufacturing and packaging batches under cGMP guidelines. He will supervise technology transfers and serve as the company’s experimental design expert in both formulation development and process optimization.
Prior to joining the company, Dr. DeHart worked for several contract pharmaceutical manufacturing companies, where his responsibilities involved reverse engineering and developing analytical methods. Most recently, he was a development scientist at a commercial manufacturing site for Catalent Pharma Solutions, where he facilitated the technology transfer and scale up of solid oral dosage forms.

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016